Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Bio Matters: OMRF’s Larry Kennedy

Get in Touch

By Jim Stafford

Copyright © 2014, The Oklahoma Publishing Company

Larry Kennedy subscribes to the random walk theory of scientific discovery.

There is something special to Kennedy about walking down the hallways at the Oklahoma Medical Research Foundation and talking science with a colleague. That’s been part of his job for the past 16 years as OMRF’s vice president for technology transfer.

Kennedy catches up on the latest discoveries from chance meetings in the halls, sits in on scientific seminars and crashes departmental meetings — all with a purpose.

The walks, the seminars and the meetings keep him in touch with the foundation’s emerging research, helping him identify discoveries with the best potential to do the greatest good for people with life-threatening or crippling illnesses.

“If you love science and you can walk-in and participate in discussions on the cutting edge of science, how much better can it get?” he said. “The scientists here are phenomenal. There are some brilliant people here.”

Larry KennedyOMRF is an Oklahoma City-based private, nonprofit biomedical research institute founded 68 years ago. The foundation conducts research into the areas of cancer, diabetes, heart disease, lupus and children’s diseases.

Kennedy, 71, will say goodbye to his scientific colleagues and their hallway conversations on Valentine’s Day when he retires from his position at OMRF. He plans to spend his retirement years in Aspen, Colo.

Trained as a microbiologist, Kennedy’s career began as a researcher, but evolved into business development roles for the pharmaceutical industry.

Kennedy’s departure from OMRF will be his third retirement, he says with a laugh. He “retired” twice from pharmaceutical companies before his tenure began at the foundation.

OMRF was supposed to be a temporary layover on the road to permanent retirement.

Because of Oklahoma City’s proximity to his hometown of Wichita, Kan., Kennedy could commute to Kansas on weekends to care for his elderly parents and those of his wife.

The “layover” at OMRF continued long after their deaths. It lasted long enough that Kennedy was able to shepherd a potentially groundbreaking discovery with special importance to him into human clinical trials.

He calls the OMRF glioblastoma project the highlight of his entire 16-year tenure.

Glioblastomas are the most common form of primary brain tumor that kill most of its victims within a year of diagnosis. A glioblastoma claimed Kennedy’s brother, John, almost two decades ago.

“My brother died of a brain tumor at age 45, at the height of his productivity,” Kennedy said. “He was diagnosed and was dead a year and a half later.”

The foundation’s glioblastoma project uses a compound called OKN-007 developed by OMRF scientists Drs. Robert Floyd and Rheal Towner. OKN-007 showed great promise in shrinking tumors in animal models.

A two-year clinical trial involving glioblastoma patients began last year at two sites: the Peggy and Charles Stephenson Cancer Center at the University of Oklahoma and the Huntsman Cancer Center in Salt Lake City, Utah. Kennedy had a direct role in the clinical trial, developing the plan himself.

The glioblastoma project is just one of many groundbreaking discoveries emerging from OMRF labs, he said.

“There are so many really neat discoveries here that could be developed into lifesaving drugs,” Kennedy said. “A lot of the young, productive scientists that we’ve hired in the last five years or so are really going to start to flourish.”

When future discoveries at OMRF emerge from its laboratories, Kennedy will have to read about them from his Aspen home. His days of random walks and scientific discovery are over.

Jim Stafford is a communications specialist with i2E Inc. in Oklahoma City.

 Click here to read the article at newsok.com

Author

  • admin admin

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E